Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 2—February 2019
Dispatch

Crimean-Congo Hemorrhagic Fever, Kosovo, 2013–2016

Salih Ahmeti1, Lindita Berisha1, Bahrije Halili, Florim Ahmeti, Ronald von Possel, Corinna Thomé-Bolduan, Anett Michel, Simone Priesnitz, Emil C. Reisinger, Stephan Günther, Andreas Krüger, Kurtesh Sherifi, Xhevat Jakupi, Christoph J. HemmerComments to Author , and Petra Emmerich
Author affiliations: University Hasan Prishtina, Prishtina, Kosovo (S. Ahmeti); University Clinical Center of Kosovo, Prishtina (L. Berisha, B. Halili); National Institute of Public Health of Kosovo, Prishtina (F. Ahmeti, X. Jakupi); Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany (R. von Possel, C. Thomé-Bolduan, S. Günther,; P. Emmerich); Bundeswehr Hospital, Hamburg (A. Michel, S. Priesnitz, A. Krüger); University of Rostock, Rostock, Germany (E.C. Reisinger, C.J. Hemmer, P. Emmerich); University Hasan Prishtina Faculty of Agriculture and Veterinary Science, Prishtina (K. Sherifi)

Main Article

Figure 1

Municipalities (komunë) in Kosovo, showing number of patients with Crimean-Congo hemorrhagic fever in each municipality. Map was obtained from Wikimedia, where it is available to the public under the GNU Free Documentation License (13). The original map has no invariant elements; it has been modified to indicate patient locations.

Figure 1. Municipalities (komunë) in Kosovo, showing number of patients with Crimean-Congo hemorrhagic fever in each municipality. Map was obtained from Wikimedia, where it is available to the public under the GNU Free Documentation License (13). The original map has no invariant elements; it has been modified to indicate patient locations.

Main Article

References
  1. Appannanavar  SB, Mishra  B. An update on crimean congo hemorrhagic Fever. J Glob Infect Dis. 2011;3:285–92. DOIPubMedGoogle Scholar
  2. Estrada-Peña  A, Palomar  AM, Santibáñez  P, Sánchez  N, Habela  MA, Portillo  A, et al. Crimean-Congo hemorrhagic fever virus in ticks, Southwestern Europe, 2010. Emerg Infect Dis. 2012;18:179–80. DOIPubMedGoogle Scholar
  3. Negredo  A, de la Calle-Prieto  F, Palencia-Herrejón  E, Mora-Rillo  M, Astray-Mochales  J, Sánchez-Seco  MP, et al.; Crimean Congo Hemorrhagic Fever@Madrid Working Group. Autochthonous Crimean-Congo Hemorrhagic Fever in Spain. N Engl J Med. 2017;377:154–61. DOIPubMedGoogle Scholar
  4. Vesenjak-Hirjan  J, Punda-Polić  V, Dobe  M. Geographical distribution of arboviruses in Yugoslavia. J Hyg Epidemiol Microbiol Immunol. 1991;35:129–40.PubMedGoogle Scholar
  5. Ahmeti  S, Kutllovci  M, Bajrami  M. Crimean Congo hemorrhagic fever in Kosova during 1995. Praxis Medica. 1996;39:11–6.
  6. Sherifi  K, Cadar  D, Muji  S, Robaj  A, Ahmeti  S, Jakupi  X, et al. Crimean-Congo hemorrhagic fever virus clades V and VI (Europe 1 and 2) in ticks in Kosovo, 2012. PLoS Negl Trop Dis. 2014;8:e3168. DOIPubMedGoogle Scholar
  7. Duh  D, Saksida  A, Petrovec  M, Ahmeti  S, Dedushaj  I, Panning  M, et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis. 2007;13:1769–72. DOIPubMedGoogle Scholar
  8. Hasanoğlu  I, Guner  R, Carhan  A, Kocak Tufan  Z, Yagci-Caglayik  D, Guven  T, et al. Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load. J Clin Virol. 2016;75:42–6. DOIPubMedGoogle Scholar
  9. Karlberg  H, Tan  YJ, Mirazimi  A. Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. J Biol Chem. 2011;286:3227–34. DOIPubMedGoogle Scholar
  10. Emmerich  P, Jakupi  X, von Possel  R, Berisha  L, Halili  B, Günther  S, et al. Viral metagenomics, genetic and evolutionary characteristics of Crimean-Congo hemorrhagic fever orthonairovirus in humans, Kosovo. Infect Genet Evol. 2018;65:6–11. DOIPubMedGoogle Scholar
  11. Johnson  S, Henschke  N, Maayan  N, Mills  I, Buckley  BS, Kakourou  A, et al. Ribavirin for treating Crimean Congo haemorrhagic fever. Cochrane Database Syst Rev. 2018;6:CD012713.PubMedGoogle Scholar
  12. Oestereich  L, Rieger  T, Neumann  M, Bernreuther  C, Lehmann  M, Krasemann  S, et al. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS Negl Trop Dis. 2014;8:e2804. DOIPubMedGoogle Scholar
  13. TUBS. Map of administrative divisions of Kosovo. 2013 Oct 22 [cited 2017 Nov 7]. https://commons.wikimedia.org/wiki/File:Kosovo,_administrative_divisions_(municipalities)_-_de_-_monochrome.svg

Main Article

1These first authors contributed equally to this article.

Page created: January 18, 2019
Page updated: January 18, 2019
Page reviewed: January 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external